vs
Side-by-side financial comparison of Allstate (ALL) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.
BeOne Medicines Ltd. is the larger business by last-quarter revenue ($1.5B vs $922.0M, roughly 1.6× Allstate). Allstate runs the higher net margin — 266.6% vs 4.4%, a 262.2% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 7.2%). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs -75.8%).
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. The company operates through Allstate Protection; Protection Services; Allstate Health and Benefits; and Run-off Property-Liability segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; specialty auto products, including motorcycle, trailer, motor home, and off-road vehicle insurance; other personal ...
BeOne Medicines Ltd.ONCEarnings & Financial Report
BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.
ALL vs ONC — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $922.0M | $1.5B |
| Net Profit | $2.5B | $66.5M |
| Gross Margin | — | 90.5% |
| Operating Margin | -1400.3% | 12.4% |
| Net Margin | 266.6% | 4.4% |
| Revenue YoY | 7.2% | 32.8% |
| Net Profit YoY | — | 143.8% |
| EPS (diluted) | $9.25 | $0.05 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $922.0M | — | ||
| Q4 25 | $17.3B | $1.5B | ||
| Q3 25 | $17.3B | $1.4B | ||
| Q2 25 | $16.6B | $1.3B | ||
| Q1 25 | $16.5B | $1.1B | ||
| Q4 24 | $16.5B | $1.1B | ||
| Q3 24 | $16.6B | $1.0B | ||
| Q2 24 | $15.7B | $929.2M |
| Q1 26 | $2.5B | — | ||
| Q4 25 | $3.8B | $66.5M | ||
| Q3 25 | $3.7B | $124.8M | ||
| Q2 25 | $2.1B | $94.3M | ||
| Q1 25 | $595.0M | $1.3M | ||
| Q4 24 | $1.9B | $-151.9M | ||
| Q3 24 | $1.2B | $-121.3M | ||
| Q2 24 | $331.0M | $-120.4M |
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 86.1% | ||
| Q2 25 | — | 87.5% | ||
| Q1 25 | — | 85.2% | ||
| Q4 24 | — | 85.8% | ||
| Q3 24 | — | 83.0% | ||
| Q2 24 | — | 85.1% |
| Q1 26 | -1400.3% | — | ||
| Q4 25 | — | 12.4% | ||
| Q3 25 | — | 11.5% | ||
| Q2 25 | — | 6.7% | ||
| Q1 25 | — | 1.0% | ||
| Q4 24 | — | -7.0% | ||
| Q3 24 | — | -12.0% | ||
| Q2 24 | — | -11.5% |
| Q1 26 | 266.6% | — | ||
| Q4 25 | 22.1% | 4.4% | ||
| Q3 25 | 21.7% | 8.8% | ||
| Q2 25 | 12.7% | 7.2% | ||
| Q1 25 | 3.6% | 0.1% | ||
| Q4 24 | 11.7% | -13.5% | ||
| Q3 24 | 7.2% | -12.1% | ||
| Q2 24 | 2.1% | -13.0% |
| Q1 26 | $9.25 | — | ||
| Q4 25 | $14.24 | $0.05 | ||
| Q3 25 | $13.95 | $0.08 | ||
| Q2 25 | $7.76 | $0.06 | ||
| Q1 25 | $2.11 | $0.00 | ||
| Q4 24 | $7.07 | $-0.10 | ||
| Q3 24 | $4.33 | $-0.09 | ||
| Q2 24 | $1.13 | $-0.09 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $4.5B |
| Total DebtLower is stronger | — | $836.4M |
| Stockholders' EquityBook value | $31.6B | $4.4B |
| Total Assets | $124.0B | $8.2B |
| Debt / EquityLower = less leverage | — | 0.19× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.9B | $4.5B | ||
| Q3 25 | $8.7B | $4.0B | ||
| Q2 25 | $9.6B | $2.8B | ||
| Q1 25 | $6.5B | $2.5B | ||
| Q4 24 | $4.5B | $2.6B | ||
| Q3 24 | $7.0B | $2.7B | ||
| Q2 24 | $5.3B | $2.6B |
| Q1 26 | — | — | ||
| Q4 25 | $7.5B | $836.4M | ||
| Q3 25 | $8.1B | — | ||
| Q2 25 | $8.1B | — | ||
| Q1 25 | $8.1B | — | ||
| Q4 24 | $8.1B | — | ||
| Q3 24 | $8.1B | — | ||
| Q2 24 | $8.1B | — |
| Q1 26 | $31.6B | — | ||
| Q4 25 | $30.6B | $4.4B | ||
| Q3 25 | $27.5B | $4.1B | ||
| Q2 25 | $24.0B | $3.8B | ||
| Q1 25 | $22.1B | $3.5B | ||
| Q4 24 | $21.4B | $3.3B | ||
| Q3 24 | $20.9B | $3.4B | ||
| Q2 24 | $18.6B | $3.4B |
| Q1 26 | $124.0B | — | ||
| Q4 25 | $119.8B | $8.2B | ||
| Q3 25 | $120.4B | $7.6B | ||
| Q2 25 | $115.9B | $6.3B | ||
| Q1 25 | $115.2B | $5.8B | ||
| Q4 24 | $111.6B | $5.9B | ||
| Q3 24 | $113.7B | $5.8B | ||
| Q2 24 | $108.4B | $5.7B |
| Q1 26 | — | — | ||
| Q4 25 | 0.24× | 0.19× | ||
| Q3 25 | 0.29× | — | ||
| Q2 25 | 0.34× | — | ||
| Q1 25 | 0.37× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.39× | — | ||
| Q2 24 | 0.43× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $417.3M |
| Free Cash FlowOCF − Capex | — | $379.8M |
| FCF MarginFCF / Revenue | — | 25.4% |
| Capex IntensityCapex / Revenue | — | 2.5% |
| Cash ConversionOCF / Net Profit | — | 6.28× |
| TTM Free Cash FlowTrailing 4 quarters | — | $941.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $3.0B | $417.3M | ||
| Q3 25 | $3.3B | $402.6M | ||
| Q2 25 | $1.9B | $263.6M | ||
| Q1 25 | $2.0B | $44.1M | ||
| Q4 24 | $1.7B | $75.2M | ||
| Q3 24 | $3.2B | $188.4M | ||
| Q2 24 | $2.4B | $-95.6M |
| Q1 26 | — | — | ||
| Q4 25 | $2.9B | $379.8M | ||
| Q3 25 | $3.2B | $354.5M | ||
| Q2 25 | $1.9B | $219.8M | ||
| Q1 25 | $1.9B | $-12.3M | ||
| Q4 24 | $1.7B | $-17.3M | ||
| Q3 24 | $3.1B | $54.7M | ||
| Q2 24 | $2.3B | $-205.5M |
| Q1 26 | — | — | ||
| Q4 25 | 16.7% | 25.4% | ||
| Q3 25 | 18.8% | 25.1% | ||
| Q2 25 | 11.3% | 16.7% | ||
| Q1 25 | 11.4% | -1.1% | ||
| Q4 24 | 10.0% | -1.5% | ||
| Q3 24 | 18.9% | 5.5% | ||
| Q2 24 | 14.7% | -22.1% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 2.5% | ||
| Q3 25 | 0.3% | 3.4% | ||
| Q2 25 | 0.0% | 3.3% | ||
| Q1 25 | 0.6% | 5.0% | ||
| Q4 24 | 0.3% | 8.2% | ||
| Q3 24 | 0.4% | 13.3% | ||
| Q2 24 | 0.4% | 11.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.78× | 6.28× | ||
| Q3 25 | 0.88× | 3.22× | ||
| Q2 25 | 0.89× | 2.79× | ||
| Q1 25 | 3.30× | 34.71× | ||
| Q4 24 | 0.88× | — | ||
| Q3 24 | 2.69× | — | ||
| Q2 24 | 7.13× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
